RA patients (n = 53) | Controls (n = 53) | P | |
---|---|---|---|
Age, years, median (min–max) | 45.00 (26–73) | 45.00 (29–68) | 0.897 |
Female, n (%) | 38 (71.7) | 40 (75.50) | 0.659 |
Postmenaposal, n (%) | 16 (42.1) | 16 (40.0) | 0.850 |
Laboratory | |||
Biochemical, mean ± SD | |||
Corrected calcium, mg/dl | 9.2 ± 0.4 | 8.8 ± 0.4 | < 0.001* |
Phosphorus, mg/dl | 3.0 ± 0.6 | 3.5 ± 0.6 | < 0.001* |
GFR, ml/minute | 101.8 ± 21.2 | 104.2 ± 23.0 | 0.576 |
Hormonal, median (min–max) | |||
25-hydroxyvitamin D, ng/ml | 10.0 (3.0–40.0) | 16.0 (5.0–29.7) | 0.002* |
PTH, pg/ml | 67.0 (16–474) | 34.4 (16–89) | < 0.001* |
FGF23, pg/ml | 20.6 (11.2–51.0) | 26.4 (12.6–49.5) | < 0.001* |